Abstract We have shown that the cellular process of macroautophagy plays a protective role in HL-1 cardiomyocytes subjected to simulated ischemia/reperfusion (sI/ R) (Hamacher-Brady et al. in J Biol Chem 281(40):29776-29787). Since the nucleoside adenosine has been shown to mimic both early and late phase ischemic preconditioning, a potent cardioprotective phenomenon, the purpose of this study was to determine the effect of adenosine on autophagosome formation. Autophagy is a highly regulated intracellular degradation process by which cells remove cytosolic long-lived proteins and damaged organelles, and can be monitored by imaging the incorporation of microtubule-associated light chain 3 (LC3) fused to a fluorescent protein (GFP or mCherry) into nascent autophagosomes. We investigated the effect of adenosine receptor agonists on autophagy and cell survival following sI/R in GFP-LC3 infected HL-1 cells and neonatal rat cardiomyocytes. The A 1 adenosine receptor agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) (100 nM) caused an increase in the number of autophagosomes within 10 min of treatment; the effect persisted for at least 300 min. A significant inhibition of autophagy and loss of protection against sI/R measured by release of lactate dehydrogenase (LDH), was demonstrated in CCPA-pretreated cells treated with an A 1 receptor antagonist, a phospholipase C inhibitor, or an intracellular Ca(?2) chelator. To determine whether autophagy was required for the protective effect of CCPA, autophagy was blocked with a dominant negative inhibitor (Atg5 K130R ) delivered by transient transfection (in HL-1 cells) or protein transduction (in adult rat cardiomyocytes). CCPA attenuated LDH release after sI/R, but protection was lost when autophagy was blocked. To assess autophagy in vivo, transgenic mice expressing the red fluorescent autophagy marker mCherry-LC3 under the control of the alpha myosin heavy chain promoter were treated with CCPA 1 mg/kg i.p. Fluorescence microscopy of cryosections taken from the left ventricle 30 min after CCPA injection revealed a large increase in the number of mCherry-LC3-labeled structures, indicating the induction of autophagy by CCPA in vivo. Taken together, these results indicate that autophagy plays an important role in mediating the cardioprotective effects conferred by adenosine pretreatment.
Introduction
The induction of ischemic tolerance in the heart to prevent and treat myocardial infarction in the setting of ischemia/ reperfusion (I/R) injury continues to be an area of intense investigation. Many of these efforts have centered around the elucidation of the mechanisms underlying the phenomenon of ischemic preconditioning with the intent to develop new therapies based on the identification of endogenous triggers and putative mediators. One agent that has been shown to mimic both acute (early) and delayed (late phase) preconditioning is the nucleoside adenosine [2, 3] . Purportedly, the cardioprotective effects of the agent are mediated via activation of various adenosine receptor subtypes, the primary one being the A 1 receptor [3] . Ligation of the adenosine A 1 receptor is followed by activation of phospholipase C (PLC) and protein kinase C (PKC) [2] . These, in turn, have been reported to confer protection by activation of an ATP-sensitive K ? (K ATP ) channel within mitochondria (mK ATP ) prior to the onset of prolonged ischemia [4, 5] . Although it has been suggested that the mK ATP channel is the end effector of ischemic preconditioning, just how activation of the mK ATP channel results in cardioprotection is unknown, although our understanding continues to grow [6] . A number of other potential effectors have been studied including anion channels, the cytoskeleton, and the closure of gap junctions [3, 7] . Our previous work in HL-1 cells indicated that suppressing autophagy in the context of simulated I/R (sI/R) increased cell death, suggesting the possibility that autophagy was part of a cellular protective response [1] . For that reason we hypothesized that autophagy might be involved in ischemic or pharmacologic preconditioning. Pharmacologic inhibitors of autophagy have off-target side effects that may confound interpretation of the results [8, 9] . For that reason we used a point mutation of the essential autophagy gene Atg5. Mutation of lysine 130 on Atg5 prevents conjugation of ubiquitin-like Atg12 onto the acceptor lysine by Atg7 [10] . We and others have shown that Atg5 K130R functions as a potent dominant negative, inhibiting autophagy at the earliest stage [1, 11, 12] . Atg5 is not known to participate in other pathways besides autophagy, and therefore Atg5 K130R is the most specific inhibitor available.
Macroautophagy (referred to hereafter as autophagy) is the only means to remove dysfunctional organelles such as mitochondria and insoluble protein aggregates [13] . The process is initiated by a number of stressors including starvation, oxidative stress, lipopolysaccharide exposure, and sI/ R injury. Many studies of autophagy now rely on scoring the number of autophagosomes, which can be detected in transfected cells or transgenic animals expressing GFP (or the red fluorescent protein mCherry) fused to the protein LC3, which is incorporated into nascent autophagosomes [14] . In the setting of myocardial sI/R injury, an increased prevalence of autophagosomes has been documented [1] . In an in vivo model of myocardial ischemia, a reduction in stunning correlated with increased expression of Beclin1 (an autophagy gene) [15] . Moreover, this group observed that within the tissue, cells with numerous autophagosomes were not TUNEL positive, suggesting that upregulating autophagy might prevent apoptosis. Since the end-effector(s) of adenosine-mediated protection is unknown, the purpose of this study was to test the hypothesis that adenosine-mediated cardioprotection requires activation of autophagy, and that autophagy is necessary and sufficient for achieving cardioprotection. To test these hypotheses, we subjected the HL-1 myocyte cell line to simulated I/R and treated mCherry-LC3 transgenic mice with 2-chloro-N(6)-cyclopentyladenosine (CCPA), a selective adenosine A 1 receptor agonist.
Experimental procedures
Reagents BAPTA-AM and Bafilomycin A1 (Baf) were purchased from EMD Biosciences (San Diego, CA, USA); CCPA, DPCPX and thapsigargin (TG) were purchased from Sigma (St. Louis, MO, USA).
Cell culture
Cells of the murine atrial-derived cardiac cell line HL-1 16 were plated in gelatin/fibronectin-coated culture vessels and maintained in Claycomb medium [16] (JRH Biosciences, Lenexa, KS) supplemented with 10% fetal bovine serum, 0.1 mm norepinephrine, 2 mm l-glutamine, 100 U/ mL penicillin, 100 U/mL streptomycin, and 0.25 lg/mL amphotericin B.
Freshly isolated adult rat cardiomyocytes were prepared from 200 to 250 g male Sprague Dawley rats, following standard methods. The animals were anesthetized with sodium pentobarbital, and all animal procedures were in accordance with institutional guidelines and approved by the Institutional Animal Care and Use Committee. After an injection of heparin (100 U/kg) into the hepatic vein, the heart was excised and the aorta was cannulated. The heart was perfused retrogradely with a Ca 2?
-free buffer followed by perfusion with 0.6 mg/mL collagenase (CLS 2, Worthington Biochemical Corporation, USA) and 8.3 lM CaCl 2 in perfusion buffer. After perfusion with collagenase solution for 15 min, the heart was minced in the same collagenase solution and the myocytes were filtered through a fine gauze. A stopping buffer containing 5% bovine calf serum and 12.5 lM CaCl 2 was added to the cells, followed by calcium stepwise reintroduction up to a concentration of 1 mM. The cells were centrifuged at 1009g for 1 min, and the pellet was washed in M199 medium (Invitrogen), containing 10 mM HEPES, 5 mM taurine, 5 mM creatine, 2 mM carnitine, 0.5% free fatty acid BSA and 100 U/mL penicillin-streptomycin. Cardiomyocytes were plated with laminin (Roche) (20 lg/ mL laminin for glass, or 10 lg/mL for plastic dishes) at 5 9 10 4 cells per dish. The cells were incubated in a 5% CO 2 incubator at 37°C for 2 h, then the medium was replaced with the same fresh medium, and the experiments were performed 24 h later. Cell viability based on rod-shaped morphology at the outset of the experiment was routinely[90%.
Transfections, infections, and protein transduction HL-1 cells were transfected with the indicated vectors using the transfection reagent Effectene (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions, achieving at least 40% transfection efficiency. For experiments aimed at determining autophagic flux, HL-1 cells were transfected with GFP-LC3 and the indicated vector at a ratio of 1:3 lg DNA. For infections, HL-1 cells or adult rat cardiomyocytes were infected with GFP-LC3 adenovirus for 2 h, washed in PBS and re-fed with the Claycomb medium or M199 medium, respectively. All the experiments were performed 20 h after infection. The dominant negative pmCherryAtg5 K130R was previously described [1] and has been deposited with Addgene. For adult cardiomyocytes, GFP-LC3 infected cells were incubated with recombinant Tat-Atg5 K130R for 30 min before adding CCPA. TatAtg5 K130R was prepared by cloning Atg5 K130R into the pHA-TAT construct previously described [17] . Recombinant protein was purified as previously described [11, 17, 18] . 
Release of LDH
Protein content and LDH activity were determined according to El-Ani et al. [20] . Briefly, 25 lL supernatants from 35 mm dishes were transferred into wells of a 96-well plate, and the LDH activities were determined with an LDH-L kit (Sigma), according to the manufacturer. The product of the enzyme was measured spectrophotometrically at 30°C at a wavelength of 340 nm as described previously [21] . The results were expressed relative to the control (X-fold) in the same experiment. Each experiment was done in triplicate and was repeated at least three times.
Nuclear staining
Cells were stained immediately after sI/R with propidium iodide (5 lg/mL), which stains nuclei of cells whose plasma membranes have become permeable because of cell damage. The assay was performed according to Nieminen et al. [22] . For counterstaining we used Hoechst 33342 (10 lM), which stains the nuclei of all cells.
Transgenic mCherry-LC3 mice-Cardiac-specific expressing mCherry-LC3 transgenic mice were created in the FVB/ N strain by pronuclear injection of murine alpha myosin heavy chain promoter driven mCherry-LC3 transgene in front of the human growth hormone poly adenylation signal [23] . Mice were injected with saline or CCPA (1 mg/kg, i.p.), and 30 min later they were euthanized with pentobarbital and the hearts excised and embedded in Optimal Cutting Temperature medium for cryosectioning and fluorescence microscopy. All animal procedures were carried out in accordance with institutional guidelines and approved by the Institutional Animal Care and Use Committee.
Statistics
The probability of statistically significant differences between two experimental groups was determined by Student's t-test. Values are expressed as mean ± SEM of at least three independent experiments unless stated otherwise.
Results

Adenosine receptor-selective effects on autophagy
We assessed the role of the adenosine A1 receptor using the selective agonist CCPA. As shown in Fig. 1 , CCPA induced autophagy in a dose-dependent fashion. Autophagy was upregulated within 10 min after the addition of CCPA, and was sustained for several hours, consistent with the kinetics of the preconditioned state. We observed an increase in the number of autophagosomes in response to CCPA in HL-1 cells (1C), neonatal rat cardiomyocytes (1D), adult cardiomyocytes (1E), and in vivo in the hearts of mCherry-LC3 transgenic mice (1F). cardiomyocytes under control conditions or 10 min after administration of 100 nM CCPA. e Representative images of adult cardiomyocytes under control conditions or 10 min after administration of 100 nM CCPA. f Transgenic mice expressing mCherry-LC3 under the aMHC promoter received an i.p. injection of saline or 1 mg/kg CCPA, then were sacrificed 30 min later and heart tissue was processed for fluorescence microscopy. The increase in fluorescent red puncta reflects upregulation of autophagy Effect of CCPA on autophagic flux under conditions of starvation or sI/R An increase in the number of autophagosomes can be due to increased formation of autophagosomes or a decrease in their clearance through lysosomal degradation. To measure flux, we inhibited autophagosomal degradation with Bafilomycin A1: an increase in the abundance of autophagosomes compared with steady state conditions (no Bafilomycin) reflects increased production. As shown in Fig. 2 , CCPA increased the percentage of cells with numerous autophagosomes under both steady-state and cumulative conditions, indicating that CCPA increases autophagy rather than interfering with degradation. CCPA has no effect on the extent of autophagy induced by starvation. Simulated ischemia and reperfusion (sI/R) results in an increase in the percentage of cells with numerous autophagosomes seen under steady state conditions, but this is due to impaired clearance rather than increased formation, as there is no significant increase in the number in the presence of Bafilomycin. Fewer autophagosomes were observed after sI/R in CCPA-treated cells. Since CCPA did not reduce autophagic flux induced by starvation, it likely does not interfere with formation of autophagosomes in response to sI/R. If autophagy is upregulated during sI/R in an attempt to respond to the stress of nutrient deprivation and oxidants, then the diminished autophagy seen in CCPAtreated cells after sI/R may indicate that the cells experienced less stress, and therefore less autophagy is required during reperfusion (reparative autophagy).
Receptor-selective effect of CCPA on autophagy and cytoprotection To confirm that the effects of CCPA were mediated through the adenosine A1 receptor, HL-1 cells were treated with CCPA in the presence or absence of the A1 receptor antagonist DPCPX under conditions of normoxia or sI/R. As shown in Fig. 3 , the upregulation of autophagy by CCPA under normoxic conditions was partially blocked by DPCPX. As expected, CCPA protected cells against sI/R as indicated by diminished LDH release and uptake of propidium iodide. Cytoprotection was abolished by DPCPX and the amount of autophagy during reperfusion, which we interpret to mean that there was more damage-hence more repair autophagy needed during reperfusion. These results suggest that the effects of CCPA on autophagy and cytoprotection are mediated through the adenosine A1 receptor.
CCPA signals autophagy through PLC and a rise in intracellular calcium
The adenosine A1 receptor is a G-protein-coupled receptor that activates phospholipase C (PLC) [24] . To determine if PLC signaling was upstream of autophagy induction by CCPA, we used the PLC inhibitor U73122 and assessed effects on autophagy and cytoprotection. As shown in Fig. 4 , PLC is required for CCPA stimulation of autophagy before ischemia; blockade of the CCPA signal through PLC results in an increase in autophagy after sI/R (repair autophagy) as well as an increase in LDH release at end of simulated ischemia.
Autophagy (induced by starvation or rapamycin) is dependent upon on the release of calcium from the sarcoendoplasmic reticulum (S/ER) [25] as is adenosine preconditioning [26] . As shown in Fig. 5 , we confirmed that chelation of cytoplasmic calcium with BAPTA-AM, or depletion of S/ER calcium stores by thapsigargin pretreatment, suppressed the induction of autophagy by CCPA, suggesting a convergence of the two processes. This is consistent with our previous findings that starvation-induced autophagic flux is also suppressed by BAPTA or thapsigargin [25] . Cytoprotection by CCPA is dependent upon autophagy
Steady State Cumulative
The foregoing results were consistent with the notion that the CCPA-mediated induction of autophagy before sI/R was cytoprotective and resulted in a diminished need for autophagy after sI/R. We have previously shown that mitochondrial damage induces autophagy as part of a repair response [11, 27] . To determine whether autophagy is required for protection mediated by CCPA, we transfected HL-1 cells with a dominant negative inhibitor of autophagy (Atg5
K130R
) or with empty vector. We confirmed that Atg5 K130R effectively suppressed autophagy (Fig. 6) . Importantly, the dominant negative inhibitor of autophagy eliminated the protective effects of CCPA after sI/R. Direct suppression of autophagy was not cytoprotective, arguing against a deleterious role for autophagy, as has been suggested by some investigators. To further validate these findings, we performed this study in adult cardiomyocytes, using cell-permeable recombinant TatAtg5 K130R to inhibit autophagy. As shown in Fig. 7 , CCPA induced autophagy in adult cardiomyocytes and conferred cytoprotection. Administration of Tat-Atg5 K130R suppressed autophagy and eliminated the protection by CCPA. It is important to note that inhibiting autophagy in the absence of CCPA did not increase LDH release under normoxic conditions nor did it exacerbate injury from sI/R, indicating that the recombinant protein is not directly cytotoxic. It also indicates that inhibiting autophagy is not protective in this cell culture model. These results provide clear and compelling evidence in support of the notion that CCPA mediates its cytoprotective effect through the induction of autophagy.
Effect of CCPA on delayed preconditioning
There are two windows of preconditioning: one is induced within minutes and lasts several hours, and the second window of protection is observed 16-24 h after the preconditioning stimulus (delayed or late phase). We treated HL-1 cells with CCPA for 10 min in the presence or absence of DPCPX, then 24 h later assessed autophagy and cytoprotection. As shown in Fig. 8 , we found that autophagy is upregulated 24 h after treatment with CCPA; as previously noted for immediate preconditioning, the amount of repair autophagy seen at reperfusion is less in CCPA-treated cells, reflecting less damage. The A1 antagonist blocked the effects of CCPA on autophagy and also abolished the cytoprotection by CCPA in the second window of protection. To determine if autophagy was required for the second window of protection, we transfected HL-1 cells with Atg5 K130R , the dominant negative inhibitor of autophagy. Atg5 K130R suppressed autophagy in the second window of protection and abolished the cytoprotective effect of CCPA (Fig. 9) . Taken together, these results indicate that CCPA mediates delayed preconditioning by a mechanism that requires autophagy. . After 24 h cells were treated for 10 min with CCPA followed by sI/R (2 h sI, 3 h R). The extent of autophagy was assessed by the intracellular distribution of GFP-LC3 by fluorescence microscopy (a). Cytoprotection was assessed by measuring LDH released into the media at the end of ischemia (b) or by propidium iodide uptake (c)
Discussion
The role of autophagy in the heart is controversial, with some findings suggesting it may be deleterious while other studies suggest a clear protective role. Ischemic and pharmacologic preconditioning are recognized as the most potent and reproducible cardioprotective interventions yet identified, but the precise intracellular mechanism remains elusive. Based on our previous observation that autophagy is upregulated during reperfusion and serves a cytoprotective role in HL-1 cells, we hypothesized that autophagy might represent a component of the mechanism of preconditioning. To test this, we relied on the HL-1 myocyte cell line, which we have evaluated in a number of studies and have found to behave nearly identically to neonatal rat cardiomyocytes with respect to the autophagic response to sI/R [1] , hydrogen peroxide [28] , lipopolysaccharide [28] , and pharmacologic preconditioning agents including CCPA. We also showed for the first time that CCPA upregulated autophagy in adult rat cardiomyocytes and in vivo in aMHC-mCherry-LC3 transgenic mice. In HL-1 cells, we found that CCPA upregulated autophagy within 10 min, and conferred cytoprotection against sI/R in the same time frame. Interestingly, the amount of autophagy observed during the reperfusion phase was less than in untreated cells subjected to sI/R. This seemingly paradoxical effect can be explained if one considers autophagy part of a repair response. In preconditioned cells, less damage occurs during ischemia, so less repair autophagy is required during the reperfusion phase. If CCPA directly suppressed autophagy, one would expect it to suppress starvation-induced autophagy, but in that setting, it has no effect. Previous studies examining the abundance of autophagosomes in tissue have failed to take into account the turnover of these transient organelles. However, an increase in autophagosomes could be due to increased production or diminished clearance through the lysosomal pathway. We used comparisons of autophagy in the absence (steady-state) and presence (cumulative) of bafilomycin A1, which prevents autophagosome-lysosome fusion, in order to assess flux. Notably, the increase in autophagy observed after sI/R is largely due to impaired clearance (no increase in the presence of Baf). CCPA increases flux before sI/R, but appears to diminish autophagosome formation after sI/R without improving clearance (no increase after Baf).
Adenosine receptor signaling has been studied extensively and a variety of selective agonists and antagonists have been developed. CCPA is generally regarded as an A1-selective agonist, and DCPCX an A1-selective antagonist. We confirmed that the effects of CCPA on autophagy and on cytoprotection were mediated through the A1 receptor. We also confirmed that the downstream activation of phospholipase C and release of S/ER Ca ?2 were required for the effects on autophagy and cytoprotection.
Previous efforts to understand the role of autophagy in the heart have used Atg5(-/-) mice or Beclin1(?/-) mice. The Atg5(-/-) mice develop a dilated cardiomyopathy, suggesting that autophagy plays an important role in normal cardiac homeostasis. The Beclin1(?/-) mice have diminished autophagy, and a previous study by Sadoshima's group indicated that these mice had smaller infarcts than their wild type littermates [29] . However, this result must be interpreted with caution. It is unknown whether other compensatory pathways are upregulated in these animals; for instance, Atg5(-/-) mice show upregulation of ERK phosphorylation that is the basis for cytoprotection [30] . Furthermore, Beclin1 contains a BH3 domain which is postulated to function as a pro-apoptotic molecule. Reduction in the abundance of a proapoptotic protein may confer protective benefit independent of effects of autophagy. However, autophagy may not be universally protective, and its connection to innate immunity implies that perturbations to autophagy (up or down) may have pleiotropic effects [28, 31, 32] .
As noted earlier, pharmacologic inhibitors of autophagy (3-MA and wortmannin) are nonspecific and may lead to confounding results. To overcome these concerns, we used a dominant negative inhibitor of autophagy, Atg5 K130R . We found that transient transfection of Atg5 K130R potently reduced autophagy and blocked the cytoprotective effect of CCPA in HL-1 cells subjected to sI/R. In the present study, cell death after sI/R was not increased by Atg5 K130R , in contrast to our previous findings [1] . However, the studies differ with respect to readout (LDH release of both transfected and non-transfected cells versus Bax translocation scored only in transfected cells), and sensitivity (detection of small differences in cell viability is better in the Bax assay). However, the present results suggest that operational autophagy may not be essential to the basal/innate . Cells were treated with CCPA for 10 min, followed by washout. 20 h later, cells were subjected to sI/R (2 h sI, 3 h R). The extent of autophagy was assessed by the intracellular distribution of GFP-LC3 by fluorescence microscopy (a) and cell death was measured by LDH release into the medium at the end of ischemia (b) resilience to cardiomyocyte ischemia, but is important to the enhanced cytoprotection mediated by CCPA.
CCPA also elicits delayed preconditioning; we found upregulation of autophagy at 24 h after a 10 min exposure to CCPA followed by washout. The effects on autophagy and cytoprotection against sI/R were receptor dependent, as they were blocked by DPCPX. The protective effects of CCPA in delayed preconditioning also depended on autophagy, as suppression of autophagy by Atg5 K130R abolished the cytoprotection.
Further studies will be necessary to determine whether other preconditioning agents also elicit autophagy, and whether autophagy is universally required for cardioprotection. These studies are based on pre-treatment; thus it is not yet clear whether autophagy plays a protective role during reperfusion. However, evidence supports the notion that the effects of preconditioning are mediated during reperfusion [33] . Postconditioning appears to involve the same signaling pathways as preconditioning [34, 35] . Although we have shown that CCPA induces autophagy in the hearts of mCherry-LC3 mice, additional studies are necessary to elucidate the role of autophagy in vivo, as well as to determine why autophagy is protective. However, the present study demonstrates, for the first time, that autophagy serves as a key mediator of protection by the adenosine A1 receptor agonist CCPA. We suggest that interventions which directly target autophagy may represent new therapeutic modalities.
